Retirement Systems of Alabama Has $73 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Retirement Systems of Alabama reduced its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 7.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 179,613 shares of the company's stock after selling 15,209 shares during the period. Retirement Systems of Alabama owned approximately 0.07% of HCA Healthcare worth $73,000,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of the stock. Oddo BHF Asset Management Sas purchased a new stake in shares of HCA Healthcare during the third quarter valued at approximately $3,278,000. American Trust acquired a new position in HCA Healthcare in the 3rd quarter worth $372,000. Franklin Resources Inc. grew its stake in shares of HCA Healthcare by 11.7% during the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company's stock valued at $660,842,000 after acquiring an additional 174,946 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new position in HCA Healthcare in the third quarter valued at about $688,000. Finally, Unigestion Holding SA raised its position in shares of HCA Healthcare by 72.2% in the 3rd quarter. Unigestion Holding SA now owns 1,595 shares of the company's stock valued at $648,000 after purchasing an additional 669 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Performance

HCA stock traded up $2.59 during trading on Friday, reaching $313.93. 1,324,454 shares of the company's stock were exchanged, compared to its average volume of 1,204,023. HCA Healthcare, Inc. has a 1-year low of $263.22 and a 1-year high of $417.14. The company's fifty day moving average price is $356.94 and its 200-day moving average price is $358.27. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a market cap of $79.52 billion, a PE ratio of 14.01, a P/E/G ratio of 1.21 and a beta of 1.63.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.84%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare's dividend payout ratio (DPR) is presently 11.85%.

Insiders Place Their Bets

In other news, SVP Phillip G. Billington sold 3,897 shares of the firm's stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company's stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the company's stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company's stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research firms recently issued reports on HCA. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. StockNews.com lowered HCA Healthcare from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. Raymond James lowered HCA Healthcare from an "outperform" rating to a "market perform" rating in a research report on Friday, November 22nd. Morgan Stanley assumed coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They issued an "equal weight" rating and a $427.00 price objective for the company. Finally, Truist Financial raised their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a "buy" rating in a research report on Monday, August 19th. One analyst has rated the stock with a sell rating, four have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average price target of $387.13.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.